Definiens AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Definiens AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12126
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include consulting and planning services, image analysis solution services, integration and deployment services and image analysis processing services. The company delivers its services in the area of clinical studies through clinical drug development, translational research and tissue diagnostics development. It has operations in Germany and the US. Definiens is headquartered in Munich, Germany.

Definiens AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Definiens AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Definiens AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Definiens AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Definiens AG, Medical Equipment, Deal Details 10
Venture Financing 10
Definiens Raises USD20.3 Million in Venture Financing Round 10
Definiens Raises US$13 Million In Venture Financing 11
Partnerships 12
Covance and Definiens Enter into Partnership 12
Definiens Enters into Co-Development Agreement with Merck 13
NeoGenomics and Definiens Enter into Agreement 14
Indivumed Partners with Definiens 15
Definiens Partners with MolecularMD 16
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 17
Acquisition 18
MedImmune Acquires Definiens for USD150 Million 18
Definiens AG – Key Competitors 19
Definiens AG – Key Employees 20
Definiens AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Jul 25, 2018: Definiens strengthens digital data and science strategy by appointing Mr. Markus Schunk as chief operating office 22
Nov 13, 2017: Definiens Strengthens Position as Global Service Provider in Biopharma 23
Jul 24, 2017: Definiens Forearms Organization for Strategic Expansion 24
Product News 25
Nov 09, 2017: Definiens Presents Cutting-Edge Data at the 32nd Annual SITC Congress 25
Other Significant Developments 26
Oct 18, 2018: Covance aDefiniens collaborate to integrate digital pathology into precision medicine design and development 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Definiens AG, Medical Equipment, Key Facts 2
Definiens AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Definiens AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Definiens AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Deals By Market, 2012 to YTD 2018 8
Definiens AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Definiens Raises USD20.3 Million in Venture Financing Round 10
Definiens Raises US$13 Million In Venture Financing 11
Covance and Definiens Enter into Partnership 12
Definiens Enters into Co-Development Agreement with Merck 13
NeoGenomics and Definiens Enter into Agreement 14
Indivumed Partners with Definiens 15
Definiens Partners with MolecularMD 16
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 17
MedImmune Acquires Definiens for USD150 Million 18
Definiens AG, Key Competitors 19
Definiens AG, Key Employees 20
Definiens AG, Subsidiaries 21

List of Figures
Definiens AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Definiens AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Definiens AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Definiens AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Definiens AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Definiens AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Definiens AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gammon Construction Ltd:企業の戦略的SWOT分析
    Gammon Construction Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Breckenridge Pharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA, is a healthcare solution provider that research, develops and markets various generic prescription products. The company offers products such as stradiol, oxcarbazepine tablets, methylprednisolone, …
  • OncoTherapy Science Inc (4564)-医療機器分野:企業M&A・提携分析
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs. The company offers products under clinical development and anti-cancer medicines. It provides technology platforms that include laser micro-beam microdissection, cDNA microarray and i …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SunEdison Inc (SUNEQ)-エネルギー分野:企業M&A・提携分析
    Summary SunEdison, Inc. (SunEdison) is a solar energy company that develops and sells photovoltaic energy solutions, and owns and operates clean power generation assets. The company also develops, manufactures and sells silicon wafer for the semiconductor industry. It also offers solar energy servic …
  • North China Pharmaceutical Group Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes formulation products, nutrition and health products, raw materials, and veterinary drugs. The company offers sirolimus capsules, clindamycin phosphate injection, mezlocillin sodiu …
  • Oci Nv:企業の戦略・SWOT・財務分析
    Oci Nv - Strategy, SWOT and Corporate Finance Report Summary Oci Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Reach PLC:企業の戦略・SWOT・財務分析
    Reach PLC - Strategy, SWOT and Corporate Finance Report Summary Reach PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Adient Plc (ADNT):企業の財務・戦略的SWOT分析
    Adient Plc (ADNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lee’s Pharmaceutical Holdings Ltd (950):製薬・医療:M&Aディール及び事業提携情報
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR r …
  • Bioaster:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioaster is a technology research institute that develops technologies and conducts research on infectious diseases and microbiology. The institute offers services in the therapeutic areas of respiratory diseases, diarrhea, AIDS and tuberculosis. It carries out technological research program …
  • Sacmi Imola S.C. :企業の戦略・SWOT・財務情報
    Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report Summary Sacmi Imola S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • University College London:企業のM&A・事業提携・投資動向
    University College London - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University College London Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • University of California San Diego-医療機器分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆